FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and deals with a preparation for the prevention of an inflammatory disease of the intestine, which represents galactooligosaccharide, which has a degree of polymerisation 3 or higher, selected from the group, consisting of trisaccharides Gal(β 1-6)-Gal(β 1-4)-Glc, Gal(β 1-3)-Gal(β 1-4)-Glc, tetrasaccharide Gal(β 1-6)-Gal(β 1-6)-Gal(β 1-4)-Glc and pentasaccharide Gal(β 1-6)-Gal(β 1-6)-Gal(β 1-6)-Gal(β 1-4)-Glc; application of the claimed galactooligosaccharide for the prevention of the inflammatory disease of the intestine; a method of preventing the inflammatory disease of the intestine, which includes peroral introduction to a mammal of an effective quantity of galactooligosaccharide.
EFFECT: group of inventions provide the powerful anti-inflammatory effect with respect to the inflammatory diseases of the intestine.
10 cl, 9 dwg, 4 ex
Authors
Dates
2014-10-10—Published
2010-04-23—Filed